BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Express Scripts
Accenture
Cipla
QuintilesIMS
Fish and Richardson
AstraZeneca
McKinsey

Generated: January 22, 2018

DrugPatentWatch Database Preview

DARVON-N W/ ASA Drug Profile

« Back to Dashboard

Which patents cover Darvon-n W/ Asa, and when can generic versions of Darvon-n W/ Asa launch?

Darvon-n W/ Asa is a drug marketed by Aaipharma Llc and is included in two NDAs.

The generic ingredient in DARVON-N W/ ASA is aspirin; propoxyphene napsylate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.
Summary for DARVON-N W/ ASA
Drug patent expirations by year for DARVON-N W/ ASA

US Patents and Regulatory Information for DARVON-N W/ ASA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaipharma Llc DARVON-N W/ ASA aspirin; propoxyphene napsylate CAPSULE;ORAL 016829-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aaipharma Llc DARVON-N W/ ASA aspirin; propoxyphene napsylate TABLET;ORAL 016863-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Colorcon
Queensland Health
Chinese Patent Office
Cerilliant
Baxter
Citi
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot